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ABSTRACT
Several reports have documented the derivation of pluripo-
tent cells (multipotent germline stem cells) from spermato-
gonial stem cells obtained from the adult mouse testis. These
spermatogonia-derived stem cells express embryonic stem
cell markers and differentiate to the three primary germ
layers, as well as the germline. Data indicate that deriva-
tion may involve reprogramming of endogenous sper-
matogonia in culture. Here, we report the derivation of
human multipotent germline stem cells (hMGSCs) from a
testis biopsy. The cells express distinct markers of pluri-
potency, form embryoid bodies that contain derivatives of
all three germ layers, maintain a normal XY karyotype,
are hypomethylated at the H19 locus, and express high
levels of telomerase. Teratoma assays indicate the pres-
ence of human cells 8 weeks post-transplantation but
limited teratoma formation. Thus, these data suggest the
potential to derive pluripotent cells from human testis
biopsies but indicate a need for novel strategies to opti-
mize hMGSC culture conditions and reprogramming.
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INTRODUCTION
Pluripotent stem cells are characterized by their ability to pro-
liferate and self-renew extensively, as well as to differentiate
[1–6]. In humans, both human embryonic stem cell (hESC) and
human embryonic germ cell (hEGC) lines were first derived in
the late 1990s [7–10]. Like other pluripotent stem cells, hESCs
and hEGCs are characterized by their ability to differentiate to
the primary germ layers in vitro and in vivo, by expression of
diagnostic cell surface markers, by specific epigenetic and ge-
netic status, and by unique culture requirements [11, 12].
Early in fetal development, just prior to or during gastrula-
tion, mouse germ cells are identified as a cluster of cells that are
termed the primordial germ cells (PGCs) and that reside in the
extraembryonic tissues at the base of the allantois [13]. These
PGCs express specific mRNA and protein markers, such as
tissue nonspecific alkaline phosphatase (TNAP), Oct4, and
Stella, markers that are also expressed in embryonic stem cells
[14–17]. Following establishment of the initial germ cell pop-
ulation, the PGCs expand in number and eventually migrate
from the extraembryonic spaces into the nascent embryonic
gonads, where they are termed gonocytes [13]. In the female, all
of the immature germ cells or gonocytes enter meiosis during
fetal development [18–20]. In contrast, in the male, the imma-
ture germ cells migrate to the basement membrane of the sem-
iniferous tubules, where they differentiate into spermatogonial
stem cells, which will provide the cells for differentiation of
sperm throughout male adult life [21].
Over the years, culture conditions for mouse spermatogonial
stem cells have been established, facilitating the characterization
of these cells and factors involved in self-renewal and differen-
tiation [22]. Nonetheless, several lines of evidence have sug-
gested that the ability to derive pluripotent germ cell lines was
restricted to the earliest stages of development (to PGCs) and
that pluripotency of germ cells was not maintained postnatally
[13, 18, 23–27]. However, recent results from mice have chal-
lenged this assumption [28–30]. The pluripotency of mouse
spermatogonia-derived stem cells termed multipotent germline
stem cells (MGSCs), multipotent adult germline stem cells, or
multipotent adult spermatogonia-derived stem cells has been
demonstrated by several criteria, including the ability to spon-
taneously differentiate into derivatives of the three primary
germ layers and to contribute to chimeras [28–30]. Notably,
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progenitor population and delineation of the time course of
acquisition of pluripotency. These studies have suggested that a
subpopulation of cells may be “reprogrammed” to a state of
pluripotency [30]. Here, we extend these studies with analysis of
the derivation of putative human multipotent germline stem
cells (hMGSCs) from a testis biopsy.
MATERIALS AND METHODS
Patient Information
Testis biopsies are routinely obtained for the diagnosis of male
fertility through the clinical practice of P.J.T. and can be used for
research following informed consent. In this study, 19 patient sam-
ples were obtained, and one hMGSC line (termed [NK (Nina
Kossack) tissue sample 7 (NK7)]) was generated from an individual
who was diagnosed with azoospermia due to acquired reproductive
tract obstruction from trauma (obstructive azoospermia). This indi-
vidual donor presented with normal hormone values (5 IU/l follicle
stimulating hormone, 2.9 IU/l luteinizing hormone, 408 ng/dl tes-
tosterone, and 13 ng/ml prolactin), normal karyotype in a blood
sample, and no detectable Y chromosome microdeletions. Histolog-
ically, testis sections showed normal spermatogenesis (supporting
information data A).
Collection of Tissue
Approximately 30–50-mg sections of testis tissue were excised and
placed into minimal essential medium  (MEM-) (Invitrogen,
Carlsbad, CA, http://www.invitrogen.com). Tissue was mechani-
cally dissected and dissociated via a two-step enzymatic incubation
process: First, tissues were incubated for 30 minutes at 37°C in
MEM- containing 10 mg/ml collagenase (Invitrogen). Spermato-
genic tubules, tissues, and cells were then centrifuged (5 minutes,
1,000 rpm) and resuspended in 2 ml of Hanks’ balanced salt
solution (Invitrogen) containing 2.2 mg/ml DNase I (Roche Applied
Science, Inc., Indianapolis, http://www.roche-applied-science.com)
and 4 mg/ml trypsin (Invitrogen) and incubated for 10 minutes at
37°C. Then, 2.5 volumes of MEM- containing 10% fetal bovine
serum (FBS) (Invitrogen) was added to the cell suspension; cells
were washed three times with phosphate-buffered saline (PBS)
(Invitrogen) and resuspended in MEM- supplemented with 10%
FBS and 1% Penicillin-Streptomycin.
Isolation of Spermatogonial Stem Cells
Initially, we explored several methods to isolate and propagate
human spermatogonial stem cells. In one approach, we treated
testicular biopsy cells as described above and simply transferred the
sample in total directly to gelatin-coated tissue culture plates. In a
second approach, we attempted to enrich for the spermatogonial
stem cell population via magnetic-activated cell sorting (MACS) for
the glial cell line-derived neurotrophic factor (GDNF) family re-
ceptor--1 (GFR-1) [31]. To induce the propagation of ESC-like
cells from testis biopsies, we further tested alternatives of plating
testicular cells directly in hESC medium without mouse embryonic
fibroblasts (MEFs), plating cells in hESC medium directly onto
MEFs, and plating cells in hESC medium with subsequent transfer
to MEFs after 8 days; hESC medium are as described [32].
Transfer and Culture Conditions of Spermatogonial
Stem Cell Colonies
Two days postplating, most testicular cells were attached to the
growing surface, and the medium was changed. After approxi-
mately 1 week, several small colonies were observed on top of the
monolayer of testicular cells. To propagate these colonies under
hESC conditions, they were manually transferred onto MEFs and
cultured in Knockout Dulbecco’s modified Eagle’s medium
(DMEM) (Invitrogen) supplemented with 20% FBS, 1 mM L-
glutamine (Invitrogen), 0.1 mM nonessential amino acids (Invitro-
gen), 0.1 mM -mercaptoethanol (Chemicon, Billerica, MA, http://
www.chemicon.com), and 10 ng/ml recombinant human basic
fibroblast growth factor (bFGF) (R&D Systems Inc., Minneapolis,
http://www.rndsystems.com), referred to hereafter as KSR medium.
To inhibit putative stem cells from differentiating, after 5 days, cells
were passaged onto ultralow-attachment dishes. Manual passaging
was performed for the two initial passages and was followed by
enzymatic digestion using a combination of 0.01 mg/ml collagenase
(100 units/ml, 37°C, 5 minutes) (Invitrogen) and trypsin (0.25% tryp-
sin/EDTA, 37°C, 5 minutes) for later passages. Prior to transfer onto
ultralow-attachment dishes (Corning Enterprises, Corning, NY, http://
www.corning.com), cells were washed three times in KSR medium.
After 2 days, putative stem cells were plated onto MEFs.
RNA Isolation and cDNA Amplification
Total RNA was extracted with the RNeasy Mini Kit (Qiagen,
Valencia, CA, http://www1.qiagen.com). cDNA was generated
from 100 ng of RNA isolated from hMGSCs cultured on MEFs at
passages 2 and 7, from hMGSCs cultured on human testicular
stromal cells, and from testicular tissue (Clontech, Mountain View,
CA, http://www.clontech.com) using SuperScript III Reverse Tran-
scriptase (Invitrogen). Subsequent polymerase chain reaction (PCR)
analysis was performed with Platinum Taq DNA Polymerase (In-
vitrogen) using 10 ng of cDNA as template to analyze expression of
the genes OCT4, SOX-2, NANOG, STELLAR, GDF3, PUMILIO1
(PUM1), PUMILIO2 (PUM2), DAZL, VASA, SCP1, SCP3, MLH1,
BOULE, and TEKT1 with primers as shown (supporting information
Table 1) and cycling as follows: 94°C for 1 minute followed by 40
cycles at 94°C, 30 seconds; 60°C, 30 seconds; and 72°C, 30 seconds.
Immunofluorescence and Alkaline Phosphatase
Staining of Undifferentiated Colonies
Alkaline phosphatase staining was accomplished via the Vector Red
Alkaline Phosphatase Substrate Kit I (Vector Laboratories, Burlin-
game, CA, http://www.vectorlabs.com), with H9 hESCs as a posi-
tive control. For immunofluorescence, undifferentiated cells were
cultured on MEFs and were fixed in 4% paraformaldehyde (PFA) in
PBS (pH 7.4) for 20 minutes. Cells were washed twice with PBS/
0.1% Tween-20 to remove residual fixative and incubated in 1%
Triton X in PBS for 30 minutes, prior to blocking in 4% normal goat
serum in PBS (Jackson Immunoresearch Laboratories, West Grove,
PA, http://www.jacksonimmuno.com) for 30 minutes followed by
incubation with antibody solution overnight at 4°C. Primary anti-
bodies included: OCT4 (1:200; Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, http://www.scbt.com), SOX2 (1:200; Chemicon),
stage-specific embryonic antigen 4 (SSEA4) (1:200; Chemicon),
TRA1–81 (1:200; Chemicon), and DAZL (1:100, protocol as de-
scribed [32]). The following day, cells were washed twice with
PBS/0.1% Tween-20, 5 minutes, and incubated with appropriate
secondary antibody (1:200; Invitrogen) in PBS. After two washes
with PBS  0.1% Tween-20 for 5 minutes, cells were mounted with
anti-fade mounting media or 4,6-diamidino-2-phenylindole (DAPI)/
PBS and viewed on a Leica DM IL microscope (Leica, Heerbrugg,
Switzerland, http://www.leica.com) or on a Zeiss LSM 510 Confo-
cal Laser Scanning Microscope (Carl Zeiss, Jena, Germany, http://
www.zeiss.com) equipped for two-photon excitation.
Spectral Karyotyping
Growing colonies were incubated with 0.1 g/ml colcemid (Gibco,
Grand Island, NY, http://www.invitrogen.com) at 37°C overnight.
Cells were enzymatically detached as described above and resus-
pended in KSR medium. To achieve single-cell suspension, cells
were pelleted at 1,000 rpm for 5 minutes, resuspended in 0.25%
trypsin/EDTA (Gibco), and incubated at 37°C for 5 minutes. KSR
was added to inactivate the trypsin; cells were pelleted and resus-
pended in 0.4% sodium citrate and 0.4% KCl at a 1:1 ratio and
incubated at 37°C for 15 minutes. An equal volume of Carnoy’s
solution (3:1 ratio of methanol to acetic acid) was added, followed
by incubation at room temperature for 5 minutes, to fix cells (this
step was repeated twice with fresh fixative). Finally, pellets were
resuspended in a small volume of fixative and transferred to micro-
scope slides. Spectral karyotyping (SKY) analysis was performed
using SkyPaint Human H-10 according to the manufacturer’s in-
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spectral-imaging.com) and visualized on a Leica DMR Microscope
with an Applied Spectral Imaging SD-301-VDS unit.
Short Tandem Repeat/Variable Number of Tandem
Repeat Analysis
Genomic DNA was extracted from hMGSCs via the QIAamp DNA
Mini system (Qiagen) and from tissue donor blood via the QIAamp
DNA Blood Maxi Kit (Qiagen). Genomic DNA from the hESC line
H9 was used as a negative control. Ten microliters of genomic DNA
at a concentration of 2.5 ng/l was submitted for analysis via
AmpFeSTR Identifiler PCR amplification (Applied Biosystems,
Foster City, CA, http://www.appliedbiosystems.com). Fifteen tet-
ranucleotide repeat loci and the amelogenin gender determining
marker were analyzed.
Bisulfite Sequencing Analysis
hMGSCs were cultured in feeder-free conditions for 2 days, col-
lected, washed with PBS, quick-frozen on dry ice, and stored at
80°C. H9 hESCs and sperm and whole-blood genomic DNA
served as controls. Genomic DNA was extracted via the QIAamp
DNA Mini system. Conversion of unmethylated cytosines was
performed via the Methyl Easy Xceed Rapid DNA Bisulphite
Modification Kit (Human Genetic Signatures, Sydney, New South
Wales, Australia, http://www.geneticsignatures.com). For bisulfite
treatment, 0.5–1 g of genomic DNA was used, resulting in a final
converted DNA concentration of 15–20 ng/l. Four microliters of
product was amplified. Seminested PCR was performed via two
rounds: (a) 94°C, 10 minutes, followed by 30 cycles of 94°C for 45
seconds, and 61°C for 45 seconds, 72°C for 1 minute, and a final
extension step of 72°C for 10 minutes; (b) 35 cycles (same condi-
tions but second set of primers). Primers were human-specific H19
forward, 5-AGGTGTTTTAGTTTTATGGATGATGG-3; H19
forward 2, 5-TGTATAGTATATGGGTATTTTTGGAGGTTT-3;
and H19 reverse, 5-TCCTATAAATATCCTATTCCCAAATA-
ACC-3, as described in Kerjean et al. [33]. PCR products were gel
purified and cloned into a TOPO vector (Invitrogen). In addition, the
DNA methylation profile of the 5-flanking region of the human OCT4
gene was analyzed. The region that was investigated was between
2,564 and 153 base pairs (bp) from the transcription start site and
contained the proximal enhancer (PE), the distal enhancer (DE), and
the proximal promoter (PP), as indicated in Figure 3. Primer pairs
OCT4–2 forward (F)/2 reverse (R), OCT4-3F/3R, OCT4-5F/R, and
OCT4-9F/R and PCR conditions were used as described in Deb-Rinker
et al. [34].
Telomerase Activity
Telomerase activity was analyzed in duplicates using the TRAPeze
ELISA Telomerase Detection Kit (Chemicon). Cells were grown,
feeder-free, for 2 days, collected, washed with PBS, and subse-
quently quick-frozen on dry ice. The hESC line HSF8 (XY) was
used as a positive control. Cells were lysed in 1 3-[(3-cholami-
dopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS) ly-
sis buffer, and protein concentration was determined via BCA assay
(Pierce, Rockford, IL, http://www.piercenet.com). Sample extracts
were diluted 1:100 with 1 CHAPS lysis buffer, using approxi-
mately 3 ng of protein per extract for the TRAPeze ELISA Telom-
erase Detection Kit assay. Amount of product was determined using
a Multiscan EX automatic microplate reader (Thermo, Inc. Milford,
MA, http://www.thermo.com). Absorbance was measured at 450
and 620 nm, and telomerase activity was determined as follows:
absorbance  A450  A620. Heat-treated extracts (99°C for 20
minutes) were analyzed in parallel as a negative control.
Differentiation of hMGSCs
To induce embryoid body (EB) formation, hMGSCs were dissociated
with trypsin, neutralized with KSR medium, and washed three times
with differentiation medium (Knockout DMEM supplemented with
20% FBS, 1 mM L-glutamine, 0.1 mM nonessential amino acids, and
0.1 mM -mercaptoethanol) prior to transfer onto ultralow-attachment
dishes. One-third of the resulting EB suspension was collected on days
0, 3, 7, 11, 14, and 21 to determine differentiation status at these time
points. RNA was isolated via the Pico Pure RNA isolation kit (Arctu-
rus, Mountain View, CA, http://www.arctur.com), transcribed into
cDNA via the WT-Ovation RNA Amplification System (NuGEN, San
Carlos, CA, http://www.nugeninc.com), and analyzed. H9 hESCs were
used as a positive control for each differentiation experiment. Real-time
PCR using TaqMan Gene Expression Assays (Applied Biosystems)
was performed to determine the expression levels of OCT4
(Hs01895061_u1), MSI1 (Hs 00159291_m1), GATA4 (Hs
00171403_m1), and neural cell adhesion molecule (NCAM)
(Hs00169851_m1) using 20 ng of cDNA per reaction. Expression
values were normalized for GAPDH and calculated as previously
described [35]. KDR expression was analyzed using SYBR green
(Applied Biosystems) reverse transcriptase (RT)-PCR. All experiments
included controls without any cDNA template for each primer set.
For teratoma assays, cells were cultured under feeder-free con-
ditions for 2 days, incubated in 0.25% trypsin/EDTA for 5 minutes
at 37°C, and transferred to KSR medium supplemented with 20%
FBS and 10 ng/l bFGF. After two washes, cells were resuspended
in 1 ml of KSR and aliquoted into two 0.5-ml tubes. Cell pellets
were collected to prepare two grafts. Phytohemagglutinin was added
to a final concentration of 0.2 mg/ml, cells were pelleted by cen-
trifugation at 10,000g for 1 minute, and the cell pellet was incubated
for 5 minutes at room temperature. The two cell pellets were
transferred into 0.4-m Millicell-CM inserts (Millipore, Temecula,
CA, http://www.millipore.com) in a 2-cm dish containing KSR
medium. Grafts were incubated overnight at 37°C and implanted
under the kidney capsule of a female SCID recipient mouse, as
described at http://mammary.nih.gov/tools/mousework/Cunha001.
Grafts were harvested and fixed with 4% PFA 8 weeks post-
transplantation. Fixed tissue was paraffin embedded, sectioned, and
stained with hematoxylin and eosin.
To investigate whether teratoma formation would be more effi-
cient if larger cell numbers and/or support cells were transplanted,
approximately 10,000 hMGSCs were combined with 1 million irradi-
ated MEFs. After two washes, cells were resuspended in 1 ml of KSR
medium and aliquoted into two 0.5-ml tubes. Cell pellets were col-
lected to prepare two grafts, and transplantation of the grafts was
performed as described above. One million irradiated MEF cells were
used to prepare two grafts, which served as a negative control.
To analyze the origin of cells in grafts, genomic DNA was
isolated using the QIAamp DNA Mini system (Qiagen). Sixty
nanograms of DNA was used as a template to detect human sex
determining region Y (SRY). A 350-bp fragment was amplified
using primers SRY forward, 5-CGCATTCATCGTGTGGTCTCG-
3, and SRY reverse, 5-AGCTGGTGCTCCATTCTTGAG-3. PCR
was performed as follows: 94°C for 1 minute and 35 cycles of 94°C
for 1 minute, 58°C for 45 seconds, and 72°C for 45 seconds.
Resulting DNA fragments were separated by gel electrophoresis.
Samples included NK7 hMGSC grafts, NK7 hMGSC genomic
DNA, human sperm genomic DNA, and genomic DNA isolated
from the tail tip of a female SCID mouse.
Immunofluorescence Staining of Differentiated
hMGSCs
To assess differentiation, hMGSCs were differentiated in EBs for 7
days; then, EBs were plated onto gelatin-coated dishes approxi-
mately 12 hours prior to immunofluorescence analysis. Markers
used were the endoderm marker von Willebrand factor (VWF), the
mesoderm marker -smooth muscle actin (ASMA), and the ecto-
derm marker nestin (NES). Prior to staining, cells were fixed with
4% PFA for 15 minutes, fixed cells were then washed with PBS and
blocked in PBS-BT for 30 minutes. Cells were incubated for 90
minutes with primary antibodies for VWF (1:400; Abcam, Cam-
bridge, MA, http://www.abcam.com) and ASMA (1:20, Abcam)
and overnight at 4°C with the NES primary antibody (1:100; Ab-
cam). Following incubation, cells were washed with 0.3% bovine
serum albumin (Sigma-Aldrich, St. Louis, http://www.sigmaaldrich.
com) plus 0.1% Triton X-100 (Sigma-Aldrich) in PBS (PBS-BT) for 5
minutes, stained with the corresponding secondary antibody at a 1:200
dilution for 1 hour, washed three times in PBS-BT, counterstained with
DAPI, and viewed on a Leica DM IL microscope.
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Neural Differentiation
NK7 hMGSCs were plated onto gelatin and were cultured until 80%
confluence was achieved. Subsequently, KSR medium was replaced
with DMEM/F12  GlutaMAX medium (Invitrogen) supplemented
with N-2 (Invitrogen) for 2 weeks. After 2 weeks in culture, the
medium was then changed to Neurobasal Medium (Invitrogen)
supplemented with B-27 (Invitrogen) for 4 weeks. Subsequently,
the expression of ectodermal-specific markers, such as NES, mi-
crotubule-associated protein 2 (MAP2), and -tubulin III (TUB III),
was analyzed by immunofluorescence staining. NES primary anti-
body was used at a dilution of 1:100 (Abcam), MAP2 (Chemicon)
at 1:200, and TUB III (Covance, Berkeley, CA, http://www.
covance.com) at 1:750.
RESULTS
Isolation of hMGSCs from Human Testis Biopsies
In initial attempts to isolate hMGSCs, we obtained testis biop-
sies and generated cell suspensions by enzymatic digestion. We
then sought to enrich for the spermatogonial stem cell popula-
tion by MACS with the cell surface marker GFR- (the receptor
for GDNF). GFR- had previously been reported to localize to
a subset of type A spermatogonia in mice [36]. Isolated cells
were cultured on gelatin-coated dishes in MEM-. However,
although the resulting cells were capable of being propagated in
vitro, they had an elongated spindle-shaped appearance (similar
to fibroblasts), distinctly different from that of hESCs, and
lacked characteristic expression of cell surface markers of plu-
ripotent cells.
Thus, we explored alternative methods to induce the prop-
agation of hESC-like cells from testis biopsies: (a) culture of
testicular cells in hESC medium post-biopsy digestion; (b) cul-
ture of testicular cells in hESC medium for 8 days postdigestion,
with subsequent transfer onto MEFs; and (c) transfer directly
onto MEFs in hESC media. We noted that all three of these
approaches, in contrast to MACS separation, resulted in the
formation of colonies. However, these colonies could not be
successfully propagated in vitro; with passaging via trypsin
digestion, the cultures would progressively become devoid of
stem cell-like cell colonies. Thus, in 17 of 17 biopsies subjected
to these protocols, no hMGSC line was derived. In contrast, as
described below, by manual passaging we succeeded in the
derivation of two hMGSC lines (although one patient withdrew
from the study, and materials were discarded in that case).
Figure 1. Morphological analysis and anal-
ysis for the expression of both pluripotency-
and germ cell-specific markers. (A): Light
microscopy of spermatogonial stem cell col-
onies growing on top of a monolayer of
testicular cells approximately 2 weeks after
plating of the testicular cell suspension. (B):
After six passages in culture. (C): Spermato-
gonial stem cells in suspension. (Da): Ex-
pression analysis of embryonic stem cell-
and germ cell-specific markers in NK (Nina
Kossack) tissue sample 7 (NK7) human
multipotent germline stem cells
(hMGSCs) cultured on mouse embryonic
fibroblasts after two passages and seven pas-
sages. (Db, Dc): Expression analysis of NK7
cells cultured on human testicular stromal
cells after 10 passages and of a commer-
cially available testis sample. (Dd): Reverse
transcriptase-polymerase chain reaction
products separated by gel electrophoresis.
(E–H): Immunofluorescence staining of
hMGSCs at passage 8, for pluripotency
markers: (E): stage-specific embryonic anti-
gen 4. (F): TRA1–81. (G): Staining of
hMGSCs at passage 8 for embryonic stem
cell and germ cell-specific marker alkaline
phosphatase. Shown are two colonies with
different morphologies. (H): OCT4. (I):
SOX2. (J): Staining of hMGSCs at passage
8 for embryonic stem cell and germ cell-
specific marker DAZL. (E, F, I, J) show the
colocalization of 4,6-diamidino-2-phenylin-
dole with the corresponding pluripotency-
germ cell marker on the left side and the
respective marker on the right side of the
image. Scale bars  50 m.
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Following enzymatic dissociation of the testis biopsy, after approx-
imately 7–10 days of culture, very small colonies started to grow on
top of the monolayer of testicular cells; these colonies were man-
ually transferred onto MEFs and cultured under hESC conditions
(Fig. 1A, 1B). These cells, which we have termed hMGSCs, have
been propagated for approximately 20 passages in vitro; the current
line is designated NK7. The putative NK7 hMGSCs were passaged
once every week and have maintained the ability to form colonies
with characteristic hESC morphology. However, although the cells
in the middle of the colonies have a distinctive hESC-like appear-
ance, some of the cells at the periphery appear to differentiate and
acquire a spindle-shaped morphology, suggesting the need to op-
timize medium and/or culture and derivation conditions (Fig. 1B).
In suspension, NK7 cells continued to divide and formed EB-like
structures (Fig. 1C).
Gene Expression Analysis
RT-PCR was performed to analyze the expression of a subset of
pluripotency markers, as well as germ cell-specific genes, in the
isolated hMGSCs at passages 2 and 7 relative to a normal
human testis sample (Fig. 1D). Results demonstrated that the
hMGSCs at passages 2 and 7, grown on MEFs, express a subset
of those genes expressed in the testis, as shown (compare Fig.
1Da, 1Db with Fig. 1Dd), which includes the pluripotency
markers OCT4 (octamer-binding transcription factor-4) and
SOX2 (SRY-box 2). NANOG expression, however, could not be
detected in either the isolated hMGSCs or the testis sample.
Apart from that, expression of the hESC- and germ cell-enriched
genes STELLAR (STELLA-related), GDF3 (growth and differ-
entiation factor 3), PUM1 (PUMILIO 1), and PUM2 (PUMILIO
2) was observed. In addition, the hMGSCs expressed the germ
cell-specific gene DAZL (Deleted in AZoospermia-Like), as well
as SCP3 (Syntaptonemal Complex Protein 3) and MLH1 (Mut-L
Homolog 1). In contrast, expression of the markers VASA and
SCP1 was not detected, nor was the expression of the two
developmentally late germ cell markers BOULE and TEKT1
(Fig. 1D). Notably, however, when we cultured NK7 cells on
human testicular stromal cells, we observed the induction of
expression of later germ cell markers, including BOULE and
Figure 2. Human multipotent germline stem cells (hMGSCs) have a normal karyotype and express telomerase. (A): The DNA spectral karyotyping
experiment of undifferentiated hMGSCs at passage 8 demonstrates a normal (46,XY) karyotype. The spectral image, the 4,6-diamidino-2-phenylindole
staining, and the resulting chromosome table are shown. (B): Telomerase activity was investigated in hMGSCs at passage 6 (NK7A) and passage 8 (NK7B)
using the TRAPeze ELISA. A cell extract from HSF8 hESCs served as a positive control for this experiment. The telomerase activity was calculated as
average change in absorbance of the sample at 450 nm minus the absorbance at 690 nm. The black bars represent the samples without heat treatment, and
the white bars represent the samples with heat treatment. Abbreviations: A, absorbance; hESC, human embryonic stem cell.
142 Human Spermatogonial Stem CellsTEKT1, and loss of SOX2 expression (Fig. 1Dc). We therefore
concluded that NK7 cells lose the expression of later germ cell
markers if cultured under human ESC conditions and regain the
expression of pluripotency genes, such as SOX2, if cultured on
MEFs in human ESC conditions.
Our next aim was to examine the expression of pluripotency
markers in hMGSCs by immunofluorescence (Fig. 1E–1J). Pu-
tative hMGSCs were shown to express the human pluripotency
markers SSEA4 (Fig. 1E), TRA1–81 (keratin sulfate-related
antigens; Fig. 1F), OCT4 (Fig. 1H), and SOX2 (Fig. 1I). In
addition, the hMGSCs also stained positive for the early germ
cell and hESC marker TNAP (Fig. 1G), as well as the germ cell
lineage marker DAZL (Fig. 1J). Negative controls for all ex-
periments demonstrated that antibodies were specific, as ex-
pected.
Spectral Karyotype
To determine the karyotype of the derived NK7 hMGSC line,
SKY analysis was performed. Results demonstrated that the
NK7 hMGSC line has a normal karyotype (46, XY) and no Y
chromosome microdeletions. No indications of other cytoge-
netic abnormalities were detected (Fig. 2A). This indicated that
the derived cell line was karyotypically identical to the patient’s
somatic cells, at this level of analysis.
Telomerase Activity and Methylation of the H19
Differentially Methylated Region and the OCT4
Promoter Region
Telomerase activity is indicative of pluripotent stem cells. We
examined telomerase activity of the hMGSCs at passages 6 and
8 relative to the human XY-bearing ESC line HSF8, as a
positive control. As expected, hESCs exhibited a very high
telomerase activity with little or no residual activity in the
heat-inactivated control. Telomerase activity was also detected
in the two hMGSC extracts, with the level of telomerase activity
slightly reduced in cells that had been cultured for eight pas-
sages relative to those cultured for six passages (Fig. 2B).
Short Tandem Repeat/Variable Number of Tandem
Repeat Analysis
Short tandem repeat (STR)/variable number of tandem repeat
(VNTR) analysis was performed to determine the origin of the
NK7 hMGSCs. Samples analyzed were genomic DNA isolated
from NK7 hMGSCs, genomic DNA from the tissue donor’s
blood sample, and genomic DNA from H9 hESCs. The results
(Table 1) demonstrate that the number of short tandem repeats
on both alleles of the 15 loci that were analyzed is identical in
NK7 hMGSCs and the tissue donor’s blood sample. The prob-
ability that two randomly selected individuals would have an
identical genotype at these 15 loci is minuscule (5.01  10
18
[37]). Although H9 cells have the same number of short tandem
repeats as the NK7 hMGSCs on both alleles of the HUMTHO1
locus and on one allele of the D16S539, D18S51, and D5S818
loci, the number of short tandem repeats at all other examined
loci differed between H9 hESCs and the NK7 hMGSC line.
Bisulfite Sequencing
Bisulfite sequencing was performed to investigate the methyl-
ation status of 18 CpG (cytosine guanine) dinucleotides in the
differentially methylated region upstream of the H19 promoter
(Fig. 3A). Although the maternal H19 allele is active and
therefore unmethylated, the paternal H19 allele is methylated in
all somatic cells [38, 39]. Human ESCs, as well as human
somatic cells, carry one paternal and one maternal allele and
showed a ratio of 70%:30% and 50%:50% unmethylated to
methylated sequences, respectively, as shown (Fig. 3B). In
contrast, in mature sperm, the paternal allele of the H19 gene
was completely methylated (100% of clones), indicative of the
establishment of the unique male-specific methylation pattern at
this locus during this stage of development, (Fig. 3A). In con-
trast, when we examined the methylation status of H19 in NK7
hMGSCs at passage 8, we observed that this locus was hypo-
methylated, with 87% of clones unmethylated and only 13%
methylated (Fig. 3A, 3C).
In addition, the DNA methylation profile of the 5-flank-
ing region of the human OCT4 gene was analyzed. The
region investigated contains the PE, the DE, and the PP, as
indicated in Figure 3A. In undifferentiated cells the majority
of CpG repeats in this region are unmethylated and the gene
is therefore expressed. Analysis showed that 94% of CpG
sites in the OCT4 promoter region of human ESCs are un-
methylated, whereas only 19% of CpG repeats in blood cells
and 2% of CpG repeats in sperm cells were unmethylated.
Analysis of the methylation status of the OCT4 promoter
region of NK7 cells at passages 2 and 8 showed that 36% and
32% of CpG repeats were unmethylated, respectively (Fig.
3A, 3C). This partial demethylation is in accordance with the
finding that the OCT4 gene is activated in NK7 cells, as
demonstrated by RT-PCR and immunofluorescence staining.
Spontaneous Differentiation
Pluripotent stem cells can self-renew or differentiate to the three
primary germ layers: endoderm, mesoderm, and ectoderm. To
assess whether hMGSCs are able to spontaneously differentiate
into derivatives of the three germ layers in vitro, expression of
ectoderm-, endoderm-, and mesoderm-specific genes and pro-
teins was analyzed at different time points during differentia-
tion. H9 hESCs were used as a positive control (Fig. 4). As
shown, expression of the pluripotency marker OCT4 decreased
with differentiation, with a concomitant increase in the expres-
sion of the somatic markers MSI1 (ectoderm marker), GATA4
(endoderm marker), and KDR (mesoderm marker) in both
Table 1. Variable number of tandem repeat/STR analysis of 15
STR loci
STR loci NK7 hMGSCs NK7 donor blood H9 hESCs
Sex XY XY XX
D8S1179 136/145 136/145 124/149
D21S11 205/213 205/213 209/209
D7S820 281/281 281/281 268/276
CSF1PO 320/328 320/328 324/324
D3S1358 133/137 133/137 116/129
HUMTHO1 187/187 187/187 187/187
D13S317 228/240 228/240 220/220
D16S539 272/280 272/280 280/284
D2S1338 328/347 328/347 319/343
D19S433 110/122 110/122 114/126
HUMvWA 168/188 168/188 180/180
TPOX 230/230 230/230 238/242
D18S51 288/292 288/292 287/288
D5S818 152/152 152/152 152/156
FGA 231/240 231/240 252/260
Samples analyzed were genomic DNA isolated from NK7
hMGSCs, the tissue donor’s blood sample, and genomic DNA
from H9 hESCs. The name of each STR locus and the
corresponding number of short tandem repeats for both alleles are
listed.
Abbreviations: hESC, human embryonic stem cell; hMGSC,
human multipotent germline stem cell; NK7, NK (Nina Kossack)
tissue sample 7; STR, short tandem repeat.
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NCAM is commonly used as an ectoderm marker in hESC
research and would thus be expected to increase with differen-
tiation, its expression decreased with differentiation of hMG-
SCs. This is contrast to hESCs, which exhibited an increase in
the expression levels of NCAM (Fig. 4).
Once we examined the expression of ectoderm-, endoderm-,
and mesoderm-specific genes at the mRNA level, our next aim was
to evaluate germ layer marker expression at the protein level by
immunofluorescence. After 7 days of in vitro differentiation, dif-
ferentiated hMGSCs were positive for the endoderm-specific VWF
(Fig. 5A, 5B); ASMA, which specifically recognizes -smooth
muscle actin (Fig. 5C, 5D; mesoderm); and NES, an intermediate
filament that is expressed in early embryonic neuroepithelial stem
cells (Fig. 5E, 5F; ectoderm).
Finally, we tested the ability of hMGSCs to form teratomas
under the kidney capsule of a female immunodeficient (SCID)
mouse to investigate their differentiation capacity in vivo. The
grafts were recovered 2 months post-transplantation and
weighed 1.2 and 0.5 mg; histological evaluation showed that
extensive teratoma formation was not detected (Fig. 5G). How-
ever, as discussed further below, human cells were present in the
graft after 2 months, as demonstrated by molecular analysis
(Fig. 5H). PCR analysis of the human SRY gene product indi-
cated that the two positive control samples, NK7 genomic DNA
and sperm genomic DNA, contained a specific 350-bp band, as
did the NK7 hMGSC graft DNA. In contrast, no specific band
was amplified using female mouse genomic DNA as a template.
To investigate whether teratoma formation is supported by an
increased cell number and/or support cells, grafts were prepared
using approximately 10,000 hMGSCs accompanied by 1 million
irradiated MEFs as carrier cells. Again, the grafts were recov-
ered 2 months post-transplantation; histological analysis again
revealed a variety of cell types present but no wide-scale ex-
pansion to large teratomas as is frequently seen with hESCs.
Immunofluorescence Staining Following Induced
Neural Differentiation
NK7 hMGSCs formed colonies when they were cultured on
MEFs (Fig. 6A), whereas they grew as a monolayer when they
Figure 3. Bisulfite sequencing of the OCT4
promoter region and the DMR, located up-
stream of the H19 promoter. (A): Methyl-
ation profile of the human OCT4 and H19
genes. Each row of circles represents a sin-
gle cloned allele, and each circle represents a
single CpG site (white circles, nonmethyl-
ated cytosine; black circles, methylated cy-
tosine). Bisulfite-modified DNA from H9
human embryonic stem cells, human multi-
potent germline stem cells (NK7) at p2 and
p8, blood cells, and sperm cells were ana-
lyzed. (B): Percentages of methylated and
unmethylated clones present in the DMR of
the H19 gene, as portrayed in (A) above.
White bars indicate the percentages of un-
methylated clones, and black bars indicate
the percentages of methylated clones for
each cell type as shown along the x-axis.
(C): Percentages of methylated and unmeth-
ylated clones present in the promoter region
of the OCT4 gene, as portrayed in (A).
White bars indicate the percentages of un-
methylated clones, and black bars indicate
the percentages of methylated clones for
each cell type as shown along the x-axis.
Abbreviations: DE, distal enhancer; DMR,
differentially methylated region; NK7, NK
(Nina Kossack) tissue sample 7; p, passage;
PE, proximal enhancer; PP, proximal pro-
moter.
144 Human Spermatogonial Stem Cellswere cultured on gelatin (Fig. 6B). Prior to differentiation, the
hMGSCs were plated onto gelatin and were cultured until 80%
confluence was achieved. Subsequently, with 6 weeks of in-
duced differentiation to the neural cell lineage, immunofluores-
cence staining of neural makers was performed on the NK7 line.
Cells positive for NES could be detected after the induced
differentiation (Fig. 6D) but not in the untreated cell population
(Fig. 6C). In addition, cells stained positive for MAP2 (Fig. 6E)
and TUB III (Fig. 6F), demonstrating that NK7 hMGSCs have
the potential to differentiate toward the ectodermal (neural)
lineage.
DISCUSSION
Standard methods of generating hESC lines are limited in their
ability to generate patient- or disease-specific lines of potential
use for both basic science and clinical applications. However,
over the years, elegant studies have shown that in model organ-
isms and/or humans, somatic cells can be reprogrammed to an
undifferentiated state via methods such as somatic cell nuclear
transfer, somatic cell fusion with embryonic stem cells, and
induced pluripotent stem cell technology [40–43]. In addition,
recent reports have documented the derivation of pluripotent
stem cells from both neonatal and adult mouse testis [28–30]. In
these mouse studies, pluripotent stem cells were derived without
genetic modification via enrichment for spermatogonial stem
cells subsequent to reprogramming of MGSC colonies in cul-
ture. The resulting cells were shown to differentiate extensively
to all germ layers and the germline, bearing resemblance to
mouse embryonic stem cells [28–30].
In this study, we isolated pluripotent cells from human testis
biopsies that were manually transferred onto MEFs and cultured
under hESC culture conditions. On MEFs, the cells maintained
the ability to form colonies for at least 20 passages. The colonies
were characterized by a classic stem cell-like morphology on
plates and the formation of EB-like structures, in suspension. On
the basis of the results described above, we propose that these
cells are hMGSCs.
Diagnostic Gene Expression
The hMGSCs derived here expressed the pluripotency markers
OCT4 and SOX-2, but not NANOG. The apparent lack of
NANOG expression is in agreement with the cell origin and
NANOG expression pattern in adult testis in both humans and
mice [22]. It is known that NANOG expression is regulated by
the binding of OCT4 and SOX2 to the NANOG promoter region,
and it has therefore been suggested that all three proteins func-
tion as regulators to maintain pluripotency [44]. Recent studies
have demonstrated, however, that Nanog expression is not es-
sential for self-renewal or the differentiation potential of em-
bryonic stem cells but that instead it plays a role in establishing
the inner cell mass and germ cells in vivo and that it enhances
self-renewal of embryonic stem cells [44]. In addition to OCT4
and SOX2, the expression of other genes, such as STELLAR,
GDF3, PUM1, PUM2, DAZL, SCP3, and MLH1, was consistent
Figure 4. In vitro differentiation of human
multipotent germline stem cells (hMGSCs).
hMGSCs and H9 human embryonic stem
cells were spontaneously differentiated in
vitro over a period of 21 days. RNA was
isolated at six time points, and TaqMan re-
verse transcriptase-polymerase chain reac-
tion was performed to quantify the expres-
sion of the pluripotency marker OCT4 and
the somatic genes NCAM, MLH1 (ectoderm
marker), GATA4 (endoderm marker), and
KDR (mesoderm marker). Expression values
were calculated as previously described [35]
and were normalized using GAPDH as a
reference. Abbreviation: NCAM, neural cell
adhesion molecule.
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expression of a late marker of male germ cell development
(TEKT1) was not detected [48]. This expression pattern dem-
onstrates that hMGSCs express pluripotency markers, early-
stage germ cell markers, and a subset of later-stage germ cell
markers. Furthermore, the distinct expression patterns of NK7
cells grown under ESC culture conditions and NK7 cells grown
on human testicular stromal cells indicate that NK7 cells can be
reprogrammed to hMGSCs, as demonstrated by SOX2 expres-
sion and the loss of late germ cell marker expression.
Spontaneous Differentiation In Vitro
The results from the spontaneous differentiation experiment
clearly demonstrated that hMGSCs have the potential to differ-
entiate into derivatives of the three primary germ layers in vitro.
When transferred to differentiation media, the expression of
OCT4 decreased dramatically in hMGSCs, as well as in hESCs,
in parallel. We also noted that the expression of NCAM, which
has been used as an ectodermal marker for hESC differentiation,
decreased during in vitro differentiation of hMGSCs. Although
this was initially unexpected, closer scrutiny indicated that
NCAM is expressed in male germline cells and may function in
spermatogonial stem cells as a receptor for GDNF, as described
[49, 50]. Thus, the decrease in NCAM expression further sup-
ports the results of somatic differentiation, as indicated by the
increase in expression of the somatic differentiation markers
MSI1, GATA4, and KDR at both the RNA and protein levels.
These markers have previously been shown to be expressed
solely in differentiated hESCs [51]. The differentiation potential
of NK7 hMGSCs was further demonstrated by induced neural
differentiation. Following 6 weeks of culture in neural cell-
specific media, the expression of NES, MAP2, and TUB III
could be detected.
Figure 5. Immunofluorescence staining of
day 7 differentiated human multipotent
germline stem cells and teratoma analysis.
Attached EBs were assessed for protein ex-
pression as shown in (A-F). (A): von Wille-
brand factor (VWF). (B): VWF with 4,6-
diamidino-2-phenylindole (DAPI) overlay.
(C): -Smooth muscle actin (ASMA). (D):
ASMA with DAPI overlay. (E): Nestin
(NES). (F): NES with DAPI overlay. Scale
bars  50 m. (G): Analysis of teratomas 8
weeks post-transplantation. Shown is a rep-
resentative section of the NK (Nina Kos-
sack) tissue sample 7 (NK7) cell graft after 8
weeks of in vivo differentiation. (H): Ex-
pression analysis of the human SRY gene
was performed using genomic DNA isolated
from an NK7 paraffin-embedded tissue slide
(lane 1), NK7 genomic DNA (lane 2), sperm
genomic DNA (lane 3), and female mouse
genomic DNA as template (lane 4). Shown
are polymerase chain reaction products sep-
arated by gel electrophoreses. The fragment
amplified with the SRY primers had a size of
350 base pairs. Abbreviation: SRY, sex de-
termining region Y.
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We observed that the karyotype of the putative hMGSCs, as
well as the somatic cells of the patient who donated the biopsy,
was normal. Furthermore, genetic analysis indicated that the
hMGSCs were undoubtedly derived from the testis biopsy of the
man who donated the sample for research and not a laboratory/
cell contaminant. There was no evidence of common karyotypic
abnormalities associated with germ cell tumors, such as ampli-
fication of chromosome 12p [52–55].
In addition to normal karyotype, hMGSCs possess telomer-
ase activity in vitro. In immortal cells, such as hESCs, germ
cells, or cancer cells, the shortening of telomere length is pre-
vented by telomerase [56–58]. In this study, we observed a
decrease in telomerase activity after two consecutive passages
that may indicate that the current culture conditions require
further optimization to enhance proliferative capacity, or stabil-
ity, of the spermatogonial stem cells in vitro. Other cell types,
including somatic cells and sperm, demonstrated little or no
telomerase activity, as expected. These findings parallel those in
mice [24, 28–30].
Methylation Analysis
To further probe origins and status of the hMGSCs, we exam-
ined methylation of the imprinted locus, H19, a locus normally
expressed differentially from the male and female germline.
Numerous studies over the years have demonstrated that H19 is
methylated in the male germline; nonetheless, the timing of
imprint erasure and the re-establishment of the male-specific
methylation pattern in human germ cell development has not
been completely elucidated. It seems most likely that de novo
methylation is established before the germ cells enter meiosis
[33]. Results of methylation analysis described above showed a
ratio of 70% unmethylated to 30% methylated in hESCs, in line
with previous studies of hESC imprints [12], and 50%:50% in
human blood cells, as expected [38, 39]. Moreover, sperm cells
carry only the paternal allele of the H19 gene and were 100%
methylated, which is also in agreement with published findings
[33]. The hMGSCs at passage 8, however, were hypomethyl-
ated, with 87% of the clones being unmethylated and only 13%
methylated, suggesting that either a subpopulation of germ cells
(such as PGCs), devoid of methylation, gave rise to the
Figure 6. Immunofluorescence staining af-
ter 6 weeks of induced neural differentiation.
Human multipotent germline stem cells were
cultured on mouse embryonic fibroblasts in
human embryonic stem cell media (A) and
were plated onto gelatin (B) prior to the
differentiation experiment. Cells were
stained for nestin (C) before the treatment
and following induced differentiation (D).
Differentiated cells were also stained for the
ectodermal markers microtubule-associated
protein 2 (E) and -tubulin III (F). Scale
bars  50 m.
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led to imprint erasure.
Recent studies have shown that reprogramming of somatic
cells is associated with demethylation of OCT4 regulatory re-
gions, with the most apparent changes occurring in the PE, DE,
and PP regions. Mosaic CpG demethylation has been shown to
be physiologically important, as it leads to the activation of the
gene. Analysis of the methylation status of the OCT4 promoter
region of NK7 cells at passages 2 and 8 demonstrated that 36%
and 32% of CpG repeats are unmethylated. This partial demeth-
ylation is in agreement with the activation of the OCT4 gene and
supports the theory that human spermatogonial stem cells are
multipotent when cultured under human ESC culture conditions.
Teratoma Assay
The results of in vivo differentiation analysis merit further
comment. We observed that hMGSCs did not induce formation
of a large teratoma (which may or may not be beneficial for
putative clinical applications). Nonetheless, PCR analysis using
primers specific for the human SRY gene indicated the presence
of human cells in the graft even after 2 months. The most likely
explanation for this finding is that some of the human cells
persist but that a larger number of cells is required for further
teratoma analysis (4,000, as used here, is at the lower limit of
detection without MEFs serving as a carrier [59]). Repetition of
the teratoma assay using 10,000 hMGSCs accompanied by 1
million irradiated MEF cells did not lead to teratoma formation
after transplantation, even though 500–1,000 murine embryonic
stem cells accompanied by 99,000 MEFs have been shown to be
sufficient to induce tumor growth [59]. These results indicate
that although hMGSCs appear to have the potential to differen-
tiate into derivatives of the three germ layers upon spontaneous
or induced in vitro differentiation, they may not have been
reprogrammed sufficiently to generate teratomas.
CONCLUSION
The ability to isolate and culture hMGSCs in vitro may facilitate
development of novel therapeutic strategies for the treatment of
infertility. For example, one side effect of cancer treatments is
the potential destruction of spermatogonial stem cells, along
with the cancer cells, with the possibility of leaving the patient
infertile [60]. To maintain fertility, testicular biopsies could be
obtained prior to the treatment, and spermatogonial stem cells
could be propagated in vitro and finally transplanted back into
the patient’s testis when the treatment is completed, if germ cell
development can be controlled.
Recent studies in mice have also indicated that spermatogo-
nial stem cells can acquire ESC traits via an as yet poorly
defined reprogramming process [28–30]. We anticipate that
pluripotent hMGSCs represent a source of patient-specific stem
cells appropriate for the study of genetic diseases in different
cell lineages in vitro and for potential novel therapeutic appli-
cations with particular application to fertility [61]. Notably,
these cells are not genetically modified as is required for gen-
eration of induced pluripotent stem cells that can be derived
from fetal or adult somatic cells [41–43]. Nonetheless, our
results suggest that the efficient derivation of hMGSCs may
require full reprogramming through the optimization of the
culture conditions. In this regard, recent studies in nonhuman
primates illuminate fundamental properties of spermatogonia
that may inform future efforts [62].
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